Chemoinformaics analysis of 5-dihydroxy-3,8-dimethoxyxanthone (chiratol)
Molecular Weight | 288.255 | nRot | 2 |
Heavy Atom Molecular Weight | 276.159 | nRig | 17 |
Exact Molecular Weight | 288.063 | nRing | 3 |
Solubility: LogS | -3.544 | nHRing | 1 |
Solubility: LogP | 2.89 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
nHA | 6 | APOL | 37.8635 |
nHD | 2 | BPOL | 18.1145 |
QED | 0.704 |
Synth | 2.407 |
Natural Product Likeliness | 1.466 |
NR-PPAR-gamma | 0.951 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.107 |
Pgp-sub | 0.005 |
HIA | 0.029 |
CACO-2 | -4.897 |
MDCK | 0.0000151 |
BBB | 0.011 |
PPB | 0.87266 |
VDSS | 0.928 |
FU | 0.142824 |
CYP1A2-inh | 0.972 |
CYP1A2-sub | 0.963 |
CYP2c19-inh | 0.311 |
CYP2c19-sub | 0.114 |
CYP2c9-inh | 0.647 |
CYP2c9-sub | 0.933 |
CYP2d6-inh | 0.562 |
CYP2d6-sub | 0.87 |
CYP3a4-inh | 0.302 |
CYP3a4-sub | 0.156 |
CL | 6.083 |
T12 | 0.69 |
hERG | 0.005 |
Ames | 0.703 |
ROA | 0.171 |
SkinSen | 0.518 |
Carcinogencity | 0.135 |
EI | 0.952 |
Respiratory | 0.325 |
NR-Aromatase | 0.826 |
Antiviral | Yes |
Prediction | 0.691221 |